Mitchell McLeod Pugh & Williams’s GSK GSK Stock Holding History

Mitchell McLeod Pugh & Williams’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$252K	Buy	+4,805	New	+$254K	0.03%	280
2022 Q3	–	Sell	-4,465	Closed	-$243K	–	231
2022 Q2	$243K	Hold	4,465	–	–	0.09%	188
2022 Q1	$243K	Hold	4,465	–	–	0.08%	203
2021 Q4	$246K	Hold	4,465	–	–	0.08%	206
2021 Q3	$213K	Hold	4,465	–	–	0.08%	211
2021 Q2	$222K	Buy	+4,465	New	+$215K	0.09%	210
2020 Q3	–	Sell	-3,976	Closed	-$203K	–	200
2020 Q2	$203K	Buy	+3,976	New	+$204K	0.12%	178

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mitchell McLeod Pugh & Williams's GSK Position: Q2 2026 in Review

Mitchell McLeod Pugh & Williams opened a new position in GSK (GSK) in Q2 2026: 4,805 shares worth $252K. The stake represents 0.03% of the portfolio and ranks #280 among its holdings. This is a return to the name: Mitchell McLeod Pugh & Williams previously reported a position in GSK as recently as Q2 2022.

Mitchell McLeod Pugh & Williams first reported a position in GSK in Q2 2020 and has held it in 7 quarters since. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Mitchell McLeod Pugh & Williams held 4,805 shares of GSK worth $252K as of Q2 2026.
GSK was a new Mitchell McLeod Pugh & Williams position in Q2 2026.
GSK made up 0.03% of Mitchell McLeod Pugh & Williams's portfolio in Q2 2026, its #280 holding.
Mitchell McLeod Pugh & Williams first reported a position in GSK in Q2 2020 and has held it in 7 quarters since.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Mitchell McLeod Pugh & Williams's 13F filing for Q2 2026, filed 11 Aug 2026.